Pharmacy

Walgreens CEO Bets on Doctors over Drugstores in Search for Growth

A year into her job as Walgreens Boots Alliance Inc.’s chief executive, Rosalind Brewer realized the company’s board wasn’t entirely sold on her plan to save its ailing drugstore business. So she took directors on the road. Together they visited a Phoenix-area medical practice belonging to VillageMD, a chain of primary-care clinics. Walgreens, months into

Walgreens CEO Bets on Doctors over Drugstores in Search for Growth Read More »

Elevance Health Announces Closing of BioPlus Acquisition

Elevance Health (NYSE: ELV) has announced the closing of its acquisition of BioPlus, a comprehensive specialty pharmacy subsidiary of CarepathRx, a portfolio company of Nautic Partners. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases, and rheumatology. The

Elevance Health Announces Closing of BioPlus Acquisition Read More »

Will CVS’ Oak Street Health Acquisition Be Worth Its $10.6B Price?

CVS Health officially announced its $10.6 billion acquisition of Oak Street Health (OSH) last week. Advisory Board’s Paul Trigonoplos, Miriam Sznycer-Taub, Sebastian Beckmann, and Eliza Dailey discuss what that (probably very long, coupon-filled) receipt means and whether the purchase will be worth it. Read the full article: Will CVS’ Oak Street Health Acquisition Be Worth

Will CVS’ Oak Street Health Acquisition Be Worth Its $10.6B Price? Read More »

Scroll to Top